Skip to main content

Advertisement

SpringerLink
Log in

Effects of deferoximine on chondrocyte alkaline phosphatase activity: Proxidant role of deferoximine in thalassemia

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

The homozygous form of β-thalassemia, the most common single gene disorder, is treated by red cell transfusion therapy. Following transfusion, the chelator, deferoximine, is administered to patients to remove excess iron. However, when this drug is given to young children, metaphyseal dysplasia and abnormalities of linear growth are frequently observed. To explore the notion that deferoximine mine interferes with endochondral growth by chelating zinc, we examined the effect of the drug on chondrocytes maintained in long-term culture. We found that deferoximine caused a dose-dependent inhibition of a wide range of functions including cell proliferation, protein synthesis (and possibly under-hydroxylation of type X collagen), and mineral deposition. Directly relevant to the mineralization process was the observation that the drug dramatically lowered the activity of alkaline phosphatase, a zinc-requiring enzyme. To test the hypothesis that enzyme inhibition was due to chelation of zinc by deferoximine, the cell culture medium was supplemented with excess zinc. However, this treatment did not overcome the deferoximine-dependent change in enzyme activity. We next examined the possibility that deferoximine, in the presence of ascorbate, could form a free radical system that would serve to inactivate the enzyme. Using alkaline phosphatase extracted from chick cartilage, we noted that the activity of the phosphatase was markedly reduced in the presence of deferoximine and ascorbate. These effects were consistant with the notion that deferoximine and ascorbate can act as a prooxidant couple. This conclusion was confirmed when we measured the oxidative activities of the system using nitroblue tetrazolium and cytochrome c. Indeed, we noted that deferoximine markedly activates the autocatalytic oxidation of ascorbate. We next investigated the possibility that the change in alkaline phosphatase activity was due to the formation of reactive oxygen radicals. Though oxygen radical scavengers and disproportionating agents did not change the activity of the enzyme, α-tocopherol provided complete protection. In conclusion, the deferoximine-ascorbate couple inactivates chondrocyte alkaline phosphatase probably by generation of free radicals. As free radicals can damage cartilage as well as other tissues, clinical regimens that are directed at elevating ascorbate levels in thalassemia need to be carefully reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Weatherall DJ (1991) The new genetics and clinical practice, 3rd ed. Oxford University Press, New York

    Google Scholar 

  2. Propper RD, Nathan DG (1982) Clinical removal of iron. Ann Rev Med 33:509–519

    Google Scholar 

  3. Piomelli S, Loew T (1991) Management of thalassemia major (Cooley's anemia). Hematol Oncol Clin North Am 5:557–569

    Google Scholar 

  4. Porter JB, Gypraki M, Burke LC (1988) Iron mobilization from hepatocyte monolayer cultures: the importance of membrane permeability and iron binding constant. Blood 72:1497–1503

    Google Scholar 

  5. Porter JB, Huehns ER (1989) Bailliere's clinical haematology, vol 2. pp 459–474

    Google Scholar 

  6. Landau H, Spie IM, Cividalli G, Rachmilewitz EA (1978) Gonadotrophin, thyrotrophin and prolactin reserve in β thalassaemia. Clin Endocrinol (Oxf) 9:163–173

    Google Scholar 

  7. Bachrach LK, Cowell CT, Holland FJ (1982) Testosterone response to a simplified human chononic gonadotropin (HCG) stimulation test in boys. Pediatr Res 16:134A

    Google Scholar 

  8. Borgna-Pilgnatti C, De Stefano P, Zonta L, Vullo C, Deanctis V, Malevendi C, Naselli A, Masera G, Gabutti V (1985) Growth and sexual maturation in thalassemia major. J Pediatr 106:150–155

    Google Scholar 

  9. De Virgillis SM, Congia F, Frau F, Argiolu F, Diana G, Cucca F, Vrsl A, Sanna S, Podda G, Fodde M, Pirastu GF, Cao A (1988) Deferoxamine-induced growth retardation in patients with thalassemia major. J Pediatr 113:661–669

    Google Scholar 

  10. Kletzky OA, Costin G, Marrs RP, Bernstein G, March CM, Mishell DR (1979) Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab 48:901–905

    Google Scholar 

  11. Saenger P, Schwartz E, Markenson AL, Graziano JH, Levine LS, New MI, Hilgartner MW (1980) Depressed serum somatomedin activity in β-thalassemia. J Pediatr 96:214–218

    Google Scholar 

  12. Hennigton AC, Wenher GA, Matthews RN, Burger HG (1981) Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major. J Clin Endocrinol Metab 52:393–398

    Google Scholar 

  13. Wenher GA, Matthews RN, Burger HG, Herington AC (1981) Lack of response of nonsuppressible insulin-like activity to short-term administration of human growth hormone in thalasemia major. J Clin Endocrinol Metab 53:806–809

    Google Scholar 

  14. Wang C, Tso SC, Todd D (1989) Hypogonadotropic hypogonadism in severe β-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy. J Clin Endocrinol Metab 68:511–516

    Google Scholar 

  15. Bronspiegel-Weintroub N, Olivieri NF, Tyler BJ, Andrews DF, Freedman MH, Holland FJ (1990) Effect of age at the start of iron chelation therapy on gonadal function in β-thalassemia major. N Engl J Med 323:713–719

    Google Scholar 

  16. Olivieri NF Harris J, Koren G, Freedman S, Templeton DM, Bailey JD, Reilly BJ (1992) Growth failure and bony changes induced by deferoximine. Am J Pediatr Hematol Oncol 14:48–56

    Google Scholar 

  17. Hartkamp MJ, Babyn PS, Olvieri NF (in press) Spinal deformities in deferoximine-treated beta-thalassemia major patients. Pediatr Radiol

  18. Scutellari PN, Orzincolo C, Franceschini F (1989) The radiographic appearance following adequate transfusion in beta-thalassemia. Skeletal Radiol 17:545–550

    Google Scholar 

  19. Orzincolo CP, Scutellari N, Castaldi G (1992) Growth plate injury of the long bones in treated beta-thalassemia. Skeletal Radiol 21:39–44

    Google Scholar 

  20. Rioja L, Girot R, Garabedian M, Cournot-Witmer G (1990) Bone disease in children with homozygous beta-thalassemia. Bone Miner 8:69–86

    Google Scholar 

  21. Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S (1991) Deferoxamine-induced bone dysplasia in patients with thalassemia major. Am J Radiol 156:561–565

    Google Scholar 

  22. Resnick D, Niwavama G (1988) Diagnosis of bone and joint disorders, 2nd ed. WB Saunders, Philadelphia

    Google Scholar 

  23. Borg DC, Schaich KM (1986) Prooxidant action of deferoximine ferioxamine: Fenton-like production of hydroxyl radicals by reduced ferioxamine. J Free Radicals in Biol Med 2:237–243

    Google Scholar 

  24. Davies MJ, Donkor R, Dunster CA, Gee CA, Jonas S, Wilson RL (1987) Deferoximineferioxamine (Deferoximineferal) an superoxide free radicals. Formation of an enzyme-damaging nitroxide. Biochem J 246:725–729

    Google Scholar 

  25. Genge BR, Sauer GR, Wu LNY, McLean FM, Wuthier RE (1988) Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. J Biol Chem 263:18513–18519

    Google Scholar 

  26. Poole AR (1991) The growth plate: cellular physiology, cartilage assembly and mineralization in cartilage: molecular aspects. Hall B, Newman S, (eds) CRC Press, Boca Raton, Fl, pp 179–212

    Google Scholar 

  27. Leboy PS, Vaias L, Uschmann B, Golub E, Adams SL, Pacifici M (1989) Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultures chick chondrocytes. J Biol Chem 264:17281–17286

    Google Scholar 

  28. Bergmeyer HU (1983) Methods of enzymatic analysis, vol 3. Verlag Chemie, Fl, p 118.

    Google Scholar 

  29. Golub EE, Schattschneider SC, Berthold P, Burke A, Shapiro IM (1983) Induction of chondrocyte vesiculation in vitro. J Biol Chem 258:616–621

    Google Scholar 

  30. Pacifici M, Golden EB, Iwamoto M, Adams SL (1991) Retinoic acid treatment induces type X collagen gene expression in cultured chick chondrocytes. Exp Cell Res 195:38–46

    Google Scholar 

  31. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685

    Google Scholar 

  32. Golub EE, Harrison G, Taylor AG, Camper S, Shapiro IM (1992) The role of alkakine phosphatase in cartilage mineralization. Bone Miner 17:273–278

    Google Scholar 

  33. Mordente A, Meucci A, Miggiano GAD, Martorana GE (1990) Prooxidant action of deferrioxamine: enhancement of alkaline phosphatase inactivation by interaction with ascorbate system. Arch Biochem Biophys 277:234–240

    Google Scholar 

  34. Buettner GR (1990) Ascorbate oxidation: uv absorbance of ascorbate and ESR spectroscopy of the ascorbyl radical as asays for iron. Free Radic Res Commun 10:5–9

    Google Scholar 

  35. Halliwell B (1985) Use of desferoximine as a “probe” for iron-dependent formation of hydroxyl radicals. Biochem Pharmacol 34:229–233

    Google Scholar 

  36. Pacifici M, Oshima O, Fisher LW, Young MF, Shapiro IM, Leboy PS (1990) Changes in osteonectin distribution and levels are associated with mineralization of the chicken tibial growth cartilage. Calcif Tissue Int 47:51–61

    Google Scholar 

  37. Shapiro IM, Debolt K, Funanage V, Smith S, Tuan RS (1992) Developmental regulation of creatine kinase activity in cells of the epiphyseal growth cartilage. J Bone Miner Res 5:493–500

    Google Scholar 

  38. Dandona P, Menon RK, Houlder S, Thomas M, Hoffbrand AV, Flynn DF (1987) Serum 1,25 dihydroxy-vitamin D and osteocalcin and concentration in thalassemia major. Arch Dis Child 62:474–477

    Google Scholar 

  39. Chung C-C, Golub EE, Forbes E, Tokuoka T, Shapiro IM (1992) Mechanism of action of β-glycerophosphate on bone cell mineralization. Calcif Tissue Int 51:305–311

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, School of Dental Medicine, University of Pennsylvania, 4001 Spruce St., 19104-6003, Philadelphia, Pennsylvania, USA

    M. Hatori, J. Sparkman, C. C. Teixeira, J. Nervina & I. M. Shapiro

  2. Department of Pathology, Samuel Lunenfeld Research Institute of Mount Sinai Hospital, Toronto, Canada

    M. Grynpas

  3. University of Toronto, Toronto, Canada

    M. Grynpas

  4. Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, Canada

    N. Olivieri

Authors
  1. M. Hatori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Sparkman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. C. Teixeira
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Grynpas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Nervina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Olivieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. I. M. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatori, M., Sparkman, J., Teixeira, C.C. et al. Effects of deferoximine on chondrocyte alkaline phosphatase activity: Proxidant role of deferoximine in thalassemia. Calcif Tissue Int 57, 229–236 (1995). https://doi.org/10.1007/BF00310264

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00310264

Key words

Search

Navigation